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Although there are no known gender-related dif-
ferences in permeability barrier function in adults,
estrogens accelerate whereas testosterone retards
barrier development in fetal skin, and male fetuses
demonstrate slower barrier development than
female littermates. Moreover, prenatal administra-
tion of the androgen receptor antagonist, ¯uta-
mide, equalizes developmental rates in male and
female fetuses. Therefore, we evaluated the effects
of changes in testosterone on barrier homeostasis
in adult murine and human skin. Hypogonadal
mice (whether by castration or by treatment with
systemic ¯utamide) displayed signi®cantly faster
barrier recovery at 3, 6, and 12 h than did con-
trols, and testosterone replacement slowed barrier
recovery in castrated mice. Moreover, testosterone
directly effects the skin, as topical ¯utamide also
accelerated barrier recovery in normal male mice.
These ®ndings appear to be of physiologic signi®-
cance, since prepubertal male mice (age 5 wk) dis-
played accelerated barrier recovery in comparison
with adult postpubertal (11wk) males. These stu-
dies also appear to be relevant for humans, as a
hypopituitary human subject demonstrated
repeated changes in barrier recovery in parallel
with peaks and nadirs in serum testosterone levels
during intermittent testosterone replacement.
Mechanistic studies showed that differences in epi-
dermal lipid synthesis do not account for the tes-
tosterone-induced functional alterations. Instead,
epidermal lamellar body (LB) formation and secre-
tion both decrease, resulting in decreased extracel-
lular lamellar bilayers in testosterone-replete
animals. These studies demonstrate that ¯uctua-
tions in testosterone modulate barrier function,
and that testosterone repletion can have negative
consequences for permeability barrier homeostasis.
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T
he cutaneous permeability barrier resides in the
outermost layer of the epidermis, the stratum
corneum (SC). The SC is a highly resilient tissue
organized into a unique two-compartment system of
nucleated corneocytes embedded in a lipid-enriched,
intercellular matrix, which is enriched in ceramides, cholesterol,
and free fatty acids (Elias and Menon, 1991). This hydrophobic
mixture is organized into lamellar bilayer stacks, which mediate
both transcutaneous water loss and the percutaneous absorption of
xenobiotics. Acute and chronic perturbations in the permeability
barrier stimulate a coordinated, lipid synthetic and secretory
response in the underlying epidermis that leads to rapid restoration
of barrier homeostasis (Elias and Feingold, 1992; Elias, 1996). Yet,
little is known about the regulation of epidermal barrier home-
ostasis by circulating hormones or other biologic response
modi®ers.
In addition to their well-known effects on the pilosebaceous
apparatus (Ebling, 1957), androgens in¯uence epidermal growth
and differentiation. Keratinocytes both express androgen recep-
tors and possess the enzymatic apparatus to convert testosterone
to its active metabolite, dihydrotestosterone (Wilson and
Lasnitzki, 1971; Takayasu et al, 1980; Luu-The et al, 1994;
Eicheler et al, 1995; Thiboutot et al, 1995). Moreover, prior
studies have shown that androgens stimulate epidermal hyper-
plasia (Zackheim, 1968), and modulate epidermal differentiation
(Tammi, 1982), apparently due to an increase in the number of
cells in the granular layer (Tammi and Santti, 1989).
Furthermore, sex hormones exert important in¯uences on the
late stages of permeability barrier development in utero (Williams
et al, 1998). Whereas exogenous estrogens accelerate barrier
ontogenesis both in utero and in growth-factor-free explant
cultures, androgens delay barrier ontogenesis (Hanley et al,
1996). In addition, male fetal mice display a delay in barrier
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development versus female littermates, an effect that is reversible
when pregnant mothers are treated with the testosterone
receptor antagonist, ¯utamide (Hanley et al, 1996): although
decreased survival rates in male premature infants have been
ascribed to increased respiratory distress rates (Khoury et al,
1985), a negative in¯uence of androgens on skin development
could explain ongoing outcome differences in premature human
male versus female infants, even when treated with surfactant
replacement therapy (Allen et al, 1993; La Pine et al, 1995).
These observations in fetal skin prompted us to examine the
potential in¯uence of modulations in circulating testosterone on
permeability barrier function in adult skin. Using the well-
characterized murine model, we demonstrated differences in
barrier homeostasis in testosterone-replete versus -de®cient mice,
and in one hypogonadal human subject.
MATERIALS AND METHODS
Materials Castrated, sham-operated, and normal hairless male mice
(Sk:h1) were purchased from Charles River Laboratories (Philadelphia,
PA). Adult mice, age 11±14 wk, were used for all experiments. Serum
testosterone levels were > 1500 pg per ml in control animals and less than
20 pg per ml in castrated animals (IDEXX Veterinary Services, West
Sacramento, CA). Prepubertal male mice were utilized between 4 and 5 wk
of age. Testosterone propionate and ¯utamide was purchased from Sigma
(St. Louis, MO). Subcutaneous testosterone and ¯utamide were solubilized
in commercial peanut oil. Topical ¯utamide was solubilized in propylene
glycol:ethanol (7:3 vols) at the ®nal concentrations, volumes, areas, and
routes of administration described in the results and ®gure legends for each
experiment. Peanut oil and propylene glycol:ethanol were used as vehicles,
respectively.
One 58-y-old, hypogonadal male subject (post-transphenoidal hypo-
physectomy and radiation therapy in 1984) was studied at various points
before and after testosterone replacement (testosterone cyprionate 200 mg
IM at 3-wk intervals). Serum testosterone levels were measured in this
subject and in the castrated animals by standard radioimmunoassay.
Measurements of barrier recovery and SC integrity Transepidermal
water loss (TEWL) was measured with an electrolytic water analyzer
(Meeco, Warrington, PA). Barrier function was disrupted by sequential
cellophane tape stripping until TEWL levels reached 3±8 mg per cm2 per h
(Khoury et al, 1985; Allen et al, 1993). TEWL was then measured
immediately after acute barrier disruption and at various time intervals
thereafter, usually at 1, 3, 6, and 12 h after barrier disruption. SC integrity
was de®ned as the mean number of tape strippings required to abrogate the
barrier to > 3 mg per cm2 per h (Ghadially et al, 1995).
Lipid synthesis studies For nonpolar lipid synthesis studies, animals
(n = 8 each) ®rst were killed 1 h after barrier disruption. One centimeter
square skin samples then were obtained, and incubated immediately for 2 h
at 37°C in a 2-ml solution of 10 mM EDTA in Dulbecco's PBS, calcium
and magnesium free, containing 40 mci [14C] acetate, as described
previously (Monger et al, 1988). After stopping the reaction by
immersion in iced PBS, the epidermis was separated from the dermis,
and the quantities of labeled fatty acids and cholesterol were determined in
the epidermis after saponi®cation, extraction, and thin layer
chromatography (Grubauer et al, 1987; Mao-Qiang et al, 1993). Results
are expressed as nanomoles incorporated per hour per gram epidermis.
For glucosylceramide synthesis, animals (n = 6 each) were sacri®ced
without prior barrier disruption, and 9.6 cm2 samples were excised. The
subcutaneous fat was removed by scraping with a scalpel, and the samples
were incubated immediately for 2 h at 37°C in a 3-ml solution of 0.07 mM
Ca++ keratinocyte culture medium, containing 30 mci [3H] galactose
(American Radiolabeled Chemicals, St. Louis, MO) (Komori et al, 1999).
The samples were removed from the incubation medium to stop reactions,
and immersed in calcium/magnesium-free PBS at 60°C for 60 s to separate
the epidermis from the dermis. Total lipids were extracted from the
epidermis using the Bligh-Dyer method, as described previously (Mao-
Qiang et al, 1993), and glucosylceramide fractions were separated further
using thin layer chromatography (Holleran et al, 1991). The results are
expressed as nanomoles of galactose incorporated per hour per gram
epidermis.
Light microscopy, ultrastructural, and quantitative morphometric
studies Skin biopsy samples were taken immediately before and 3 h after
tape stripping of castrated mice, treated with either subcutaneous
testosterone or vehicle (see above; n = three from each group), and
processed for light and electron microscopy. Samples were minced to
< 0.5 mm3, ®xed in modi®ed Karnovsky's ®xative overnight, and post®xed
in either 0.5% ruthenium tetroxide or 2% aqueous osmium tetroxide, both
containing 1.5% potassium ferrocyanide, as described previously (Hou et al,
1991). After ®xation, all samples were dehydrated in graded ethanol
solutions, and embedded in an Epon-epoxy mixture. One-half micron
sections, stained with toluidine blue, were used for light microscopic
studies. Epidermal thickness and the number of nucleated cell layers in the
epidermis was measured over > 20 sites each from androgen-replete versus
vehicle-treated, castrated mice in coded micrographs by an unbiased
observer. Ultrathin sections were examined, with or without further
contrasting with lead citrate, in an electron microscope (Zeiss 10 A, Carl
Zeiss, Thornwood, NY) operated at 60 kV.
For quantitative ultrastructural studies, 10±21 pictures of the outer
stratum granulosum (SG) and the SG±SC interface at a constant original
magni®cation of 15,0003 were selected at random from each sample
group. Lamellar body density per micrograph was calculated as the number
of lamellar bodies per unit area. Assignment of organelles as lamellar bodies
required the presence of a trilaminar limiting membrane, characteristic
ellipsoidal shape, and a 0.4±0.6 mm long axis. The nucleus was excluded
from calculations of cytosolic volume. The cross-sectional area of the
cytosol was measured by integrating area measurements on the scanned
pictures with NIH image software Ver.1.62 (http:/rsb.info.nih.gov/nih-
image). The extent of lamellar body secretion was quanti®ed as the cross-
sectional area of the intercellular domain at the SG±SC junction divided by
the measured length in micrometers of the measured area. The cross-
sectional area was determined by two unrelated methods: (a) weighing
paper overlays of the region (Rassner et al, 1999); and (b) integrating area
measurement on the scanned pictures with NIH image software.
Statistical analysis For statistical analyzes, we utilized two-tailed and
paired Student's t tests with software from SPSS (Chicago, IL). Data are
expressed as mean 6 SEM with p < 0.05 considered signi®cant.
RESULTS
Barrier recovery and integrity change with testosterone
depletion/repletion To assess the impact of androgens on
permeability barrier homeostasis, we ®rst compared the kinetics of
barrier recovery in castrated versus sham-operated hairless mice.
Figure 1. Barrier recovery improves after surgical castration of male
mice. Barrier recovery was compared 8 wk after castration or sham-
operation of hairless male mice. Data shown represent mean 6 SEM;
ap < 0.05; bp < 0.001; cp < 0.005.
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Barrier recovery was assessed 1, 3, 6, and 12 h after acute disruption
by sequential tape stripping. As seen in Fig 1, the kinetics of barrier
recovery was accelerated signi®cantly at all time points in castrated
mice, with the greatest differences apparent at 1 and 3 h (Fig 1;
p < 0.001 and < 0.05, respectively). Moreover, castrated animals
displayed signi®cantly greater SC integrity than control animals
(Table I). These results show that surgically induced
hypogonadism leads to accelerated barrier recovery and enhanced
SC integrity in male mice.
To ascertain further whether accelerated barrier recovery after
castration is due to androgen depletion, we next assessed the effects
of testosterone- versus vehicle-repletion in castrated mice. Either
testosterone (5 mg per kg) or vehicle was administered subcuta-
neously once daily for 7 d followed by measurement of barrier
recovery after tape stripping. Whereas vehicle treatment did not
in¯uence barrier recovery rates, testosterone administration slowed
barrier recovery at all time points (Fig 2), with the greatest
difference at 3 h (p < 0.001). Likewise, testosterone treatment
caused a signi®cant decrease in SC integrity (Table I). These results
show that testosterone replenishment reverses the acceleration in
barrier recovery and improvement in SC integrity that occurs in
castrated mice.
To determine whether the castration-induced acceleration of
barrier recovery is speci®c for surgical castration, or a more
general attribute of testosterone de®ciency, we next assessed the
effects of medical castration on barrier recovery in normal
(noncastrated) male mice. For these studies, we administered
either the androgen-receptor antagonist, ¯utamide (50 mg per
kg), or vehicle alone subcutaneously once daily for 7 d,
followed by measurement of barrier recovery on the eighth day.
As seen in Fig 3, barrier recovery was accelerated at all time
points in the ¯utamide-treated animals. In fact, the absolute
recovery rates at each time point were virtually identical for
medical castration to those in surgically castrated animals. These
results show that testosterone depletion has positive effects on
permeability barrier homeostasis, independent of the method of
production of hypogonadism.
Testosterone in¯uences are directed at the skin We next
assessed whether the cutaneous effects of testosterone are due to
systemic alterations, or whether they are directed at the skin
itself. We were unable to utilize testosterone topically for these
studies, because of bulk lipid effects of this steroid hormone on
barrier function, which interfered with an assessment of
hormone effects. Hence, we measured barrier recovery after
seven, once-daily applications of ¯utamide (30 mg per ml) to a
2.5-cm2 area on one ¯ank of normal, noncastrated mice. The
contralateral ¯ank was treated daily with an equal volume of the
propylene glycol:ethanol vehicle alone. Topical ¯utamide
treatment accelerated barrier recovery, whereas the vehicle
applied to the contralateral ¯ank did not alter barrier recovery
rates versus vehicle applied to non¯utamide-treated mice (Fig 4).
Because ¯utamide-treatment only affected the treated ¯ank (the
contralateral ¯ank did not change signi®cantly), these results
show that the effects of testosterone are due to local, rather
than distant effects of the hormone.
Adverse effects of testosterone are demonstrable with
puberty and in testosterone-treated humans We next
asked whether the large differences in endogenous androgen
levels that occur in pre- versus postpubertal animals are
associated with changes in barrier homeostasis. Prepubertal
Table I. SC integrity in castrated, testosterone-replete versus
control mice
Animals Tape strippings 6 SEMa
Non-castrated (n = 7) 3.29 6 0.18b
Castrated + vehicle (n = 11) 4.27 6 0.14b
Castrated + testosterone (n = 11) 2.27 6 0.14b
aNumber of strippings required to abrogate barrier to TEWL > 3 mg per cm2
per h.
bDifferences between all groups are signi®cant at p < 0.001.
Figure 2. Barrier recovery worsens in castrated male mice after
systemic testosterone replacement. Castrated mice were injected
subcutaneously with either testosterone propionate (5 mg per kg) diluted
in peanut oil or peanut oil alone daily for 7 d. Barrier recovery was
measured on the eighth day. Data represent mean 6 SEM; ap < 0.1;
bp < 0.001.
Figure 3. Barrier recovery in male mice improves after systemic
¯utamide treatment. Male mice were injected subcutaneously with
¯utamide (50 mg per kg) in peanut oil or the peanut oil vehicle alone for 7
d. Barrier recovery was measured on the eighth day. Data shown represent
mean 6 SEM; *p < 0.002.
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mice display a 60%±70% reduction in serum testosterone levels
versus postpubertal animals (Overpeck et al, 1978). As seen in
Fig 5, prepubertal mice (5 wk) display more rapid barrier
recovery rates than do young adult male mice (11 wk) at
both 3 and 6 h after acute disruption (p < 0.02). Recovery rates
in the 11-wk-old mice again were comparable with those in
the somewhat older (12±14 wk), noncastrated adults described
above (cf. Figs 1±4). These results show that developmental
changes in male gonadal status are paralleled by changes in
barrier function.
To ascertain whether the adverse effects of androgens are of
potential relevance for humans, we next assessed barrier
recovery kinetics in one hypogonadal subject, who was
receiving intermittent testosterone replacement (testosterone
cyprionate 200 mg IM q. 3 wk). Measurements of barrier
function coincided with points of high (2 or 3 d after
injections) versus low (immediately prior to next injection)
serum testosterone levels. As seen in Fig 6, barrier recovery
rates were highest when serum testosterone levels approached
their nadir, while conversely, the kinetics of recovery slowed in
conjunction with high testosterone blood levels. Although all
observations were from a single subject, they achieved statistical
signi®cance (p = 0.011; by paired t test). These results suggest
that permeability barrier homeostasis in humans also changes
with alterations in serum testosterone.
Testosterone induces alterations in epidermal thickness
and a decline in lamellar body production/
secretion Finally, we assessed several potential mechanisms
that could account for the effects of androgens on barrier
homeostasis. Light microscopy revealed a slight, but signi®cant
decrease both in epidermal thickness and in the number of
nucleated cell layers in testosterone- versus vehicle-treated,
castrated animals (Table II). The synthesis of both
nonsaponi®able (primarily cholesterol) and saponi®able (fatty
acids) epidermal lipids, however, was comparable in castrated
and noncastrated animals (Table III). Thus, testosterone
repletion is accompanied by a decline in epidermal thickness,
but modulations in cholesterol and fatty acid synthesis do not
Figure 4. Barrier recovery in male mice improves after topical
¯utamide treatment. Male hairless mice were treated with topical
¯utamide in propylene glycol:ethanol vehicle (30 mg per ml) on one
(2.5 cm2) ¯ank and vehicle alone on the opposite ¯ank daily for 7 d, or
vehicle alone applied to one ¯ank of otherwise untreated mice daily for 7 d.
Barrier recovery was measured on the eighth day. Data shown represent
mean 6 SEM; ap < 0.001; b1 h: p < 0.01; 3 h: p < 0.05; 6 h: p < 0.001.
Figure 5. Barrier recovery is faster in pre-pubertal than in young
adult male mice. The kinetics of barrier recovery was measured in 4-wk-
old and 11-wk-old normal male hairless mice. Data shown represent mean
6 SEM; *p < 0.02.
Figure 6. Changes in barrier recovery in relation to testosterone
therapy in a hypogonadal human male. Barrier recovery during the
``high'' testosterone period was measured 3 d after intramuscular
injection of testosterone cyprionate (200 mg). (Vertical arrows indicate
time points of testosterone administration.) Barrier recovery during the
``low'' testosterone period was measured 3 wk after the last prior
testosterone injection. Serum testosterone was obtained at the same
time as barrier recovery measurements. Statistical signi®cance was
calculated with the Student-t test where each observation was
considered as an individual event; p < 0.01
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account for the decline in barrier homeostasis in testosterone-
replete animals.
We next assessed three ultrastructural markers of the lamellar
body secretory system, i.e., lamellar body density/lamellar body
secretion, and extracellular lamellar membrane structure, as
potential mechanisms that could explain the testosterone-
induced abnormality in barrier homeostasis. Both visual
assessment and quantitative stereologic (morphometric) measures
of randomly obtained, coded micrographs (observer-blinded)
were employed. Whereas we did not observe consistent
differences in the ultrastructure of untreated, normal versus
vehicle-treated, castrated mice in the basal state, we did ®nd
differences in the ultrastructure of the epidermis in testosterone-
replete versus vehicle-treated castrated and control mice, despite
the fact that TEWL rates were comparable under basal
conditions (Fig 7). The density of lamellar bodies (LB) in the
cytosol of cells in SG layers in testosterone-replete animals
appeared to be reduced in comparison to vehicle-treated,
castrated mice (Fig 7C, D). These observations were supported
by quantitative (stereologic) measurements, which showed a
signi®cant (25%±30%) reduction in the volume fraction of LB
in the cytosol of outermost SG cells (Fig 8; p < 0.05). In
addition, the amount of secreted contents at the SG±SC
interface also appeared to be reduced in testosterone-replete
versus control animals (Fig 7C vs 7D). Consistent with reduced
secretion, we found entombed LB within the cytosol of
Table II. Epidermal thickness in testosterone-replete versus
vehicle-treated, castrated mice
Vehicle-treated Sign. Testosterone-replete
Thickness (mm) 24.75 6 1.2 p < 0.005 17.86 6 0.86 (n = 18±25)
Nucleated cell
layers
2.28 6 0.11 p < 0.0001 1.67 6 0.11 (n = 27)
n = number of measurements on multiple, randomly obtained, and assessed skin
sections from two mice in each group (see Materials and Methods).
Table III. Lipid synthesis in castrated versus sham-operated
mice
Synthesis (nmol per gm epidermal weight per h)a
Animals Cholesterol Fatty acids TNS
Castrated 1.37 6 0.23 6.72 6 0.60 1.59 6 0.29(n = 8)
Sham-operated 1.21 6 0.25 6.95 6 0.85 1.40 6 0.30(n = 8)
aDifferences are not signi®cant; TNS = total nonsaponi®able lipids.
Figure 7. Lamellar body number and secretion appear to be impaired in testosterone-supplemented, castrated mice. (A, C) Castrated plus
testosterone-treated; (B, D) castrated plus vehicle-treated skin. In testosterone-treated animals note: (1) decreased numbers of lamellar bodies in the cytosol of
the outermost granular cell (SG); (2) decreased secreted lamellar contents at the SG±SC interface (C, arrows); (3) entombed lamellar bodies in the corneocyte
cytosol (A, long arrows); and (4) delayed extracellular processing (A, open arrows depict unprocessed lamellar material; solid arrows indicate foci where processing
into mature lamellae has occurred. Note that processing is still not completed between the second and third SC cell layer [A, SC2 and SC3]). In vehicle-
treated animals, more lamellar bodies appear to be present in the cytosol (D); more secreted material appears to be deposited at the SG±SC interface (D, open
arrows); and processing to mature lamellar membranes is complete by the SC1±SC2 interface (B, solid arrows). (A, B) Ruthenium tetroxide; (C, D) osmium
tetroxide. Scale bars: 0.5 mm.
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testosterone-replete, but not in vehicle-treated corneocytes
(Fig 7A). Furthermore, the processing of secreted LB contents
into mature lamellar bilayers appeared to be slowed (Fig 7A:
note persistence of partially processed lamellar contents at level
of SC 2±3 interface). Finally, as a result of decreased LB
formation and secretion, the absolute quantities of extracellular
lamellae in the SC interstices appeared to be reduced (Fig 7A;
note decreased lamellae between SC1 and SC2). It should be
noted that these changes in testosterone-replete animals also
differed from normal, noncastrated male animals (data not
shown), suggesting an effect of supraphysiologic levels of
injected testosterone.
As in the basal state, there were no ultrastructural differences
in LB formation, secretion, or postsecretory processing 3 h after
acute disruption in untreated, normal versus vehicle-treated,
castrated animals (untreated normals not shown). In contrast,
there were striking reductions in LB formation, secretion, and
postsecretory processing in testosterone- versus vehicle-treated,
castrated, and control animals 3 h after barrier disruption
(Fig 9C versus 9D; normal control not shown). Decreased LB
production was evidenced by: (a) diminution in the quantities
of newly secreted extracellular lamellae in testosterone-replete
animals (Fig 9A versus 9B); and (b) the presence of lacunae in
the SC interstices, which displayed decreased or absent lamellar
contents (Fig 9A, asterisks). These ultrastructural observations
were again validated by quantitative studies (Fig 8). Because the
changes in testosterone-replete, castrated animals differed from
both vehicle-treated, castrated, and untreated control skin, these
®ndings may re¯ect supraphysiologic testosterone levels. To-
gether, these results demonstrate a decrease in LB formation,
resulting in additional, postsecretory alterations in testosterone-
replete animals.
Finally, because acylglucosylceramide synthesis is linked to LB
formation (Madison et al, 1998), we next assessed glucosylcer-
amide synthesis in testosterone replete- versus vehicle-treated,
castrated animals. As seen in Table IV, testosterone status
modi®ed neither bulk glucosylceramide nor acylglucosylcera-
mide synthesis. Thus, decreased lamellar body formation with
testosterone treatment cannot be ascribed to a decline in
glucosylceramide production.
DISCUSSION
We show here that ¯uctuations in testosterone levels in¯uence
barrier homeostasis. Androgen depletion accelerated barrier
recovery, and barrier function was enhanced signi®cantly by
either surgical or medical castration, indicating that these
observations were independent of the method of androgen
depletion. In contrast, testosterone repletion adversely in¯uenced
the kinetics of barrier recovery versus sham-operated controls.
Androgen in¯uenced not only barrier function, but also SC
integrity, a measure of tissue cohesiveness. Although the dose of
testosterone administered to hypogonadal animals generally is
presumed to result in physiologic hormone levels, some of the
effects that we observed could have resulted from supraphysio-
logic levels that occur following bolus injections. Yet, the
functional differences in castrated versus sham-operated animals
re¯ect changes in hormone levels that are within the normal-
to-subnormal (hypogonadal) range. The physiologic relevance of
these opposing outcomes in permeability barrier homeostasis was
shown not only in prepubertal versus pubertal rodents, but also
in humans.
The fact that not only systemic ¯utamide, but also topical
antiandrogen applications accelerate barrier recovery, indicates
further that the androgen effects on barrier function are directed
at the skin, and not attributable to other consequences of
altered circulating androgens. Epidermis expresses both androgen
receptors (Mowszowicz et al, 1981; Coulam et al, 1983; BlaÈuer
et al, 1991) and 5-a-reductase (Wilson and Lasnitzki, 1971;
Bingham and Shaw, 1973; DubeÂ et al, 1975; Takayasu et al,
1980; Luu-The et al, 1994; Eicheler et al, 1995; Thiboutot et al,
1995), and keratinocytes can generate the more active hormone,
dihydrotestosterone (DHT), if presented with testosterone
(Wilson and Walker, 1969; Wilson and Lasnitzki, 1971; Sansone
and Reisner, 1971). Both testosterone and DHT bind to the
androgen receptor, and testosterone exerts powerful effects on
skin, independent of conversion to DHT (Randall and Ebling,
1982). At present, it is not known whether the effects of
testosterone on barrier function absolutely require prior
intracutaneous generation of DHT. Finally, the negative effect
of androgens cannot be attributed to increased sebaceous lipid
secretion, since barrier homeostasis is normal in asebia mice
(Mao-Qiang et al, unpublished observation).
Our ®ndings in adult epidermis are completely consistent with
our earlier work in fetal skin. Both in utero and in explant cultures,
testosterone inhibits whereas estrogen enhances barrier develop-
ment (Hanley et al, 1996). Hanley et al (1996) proposed further that
Figure 8. Lamellar body density is reduced in testosterone-replete,
castrated mice. Lamellar body density in the cytosol of outer
granular cells was calculated on randomly obtained, coded
micrographs (n = 15±21 each). A decline in organelle density
occurs after barrier disruption in both testosterone and vehicle-
treated animals, but lamellar body density is signi®cantly reduced in
both testosterone-replete groups. ap < 0.05.
Table IV.Glucosylceramide synthesis in testosterone- versus
vehicle-treated, castrated mice
Synthesis
(nmole per gm epidermal weight per h 310±3)a
Animals Total glucosylceramides Acylglucosylceramides
Castrated + testosterone
(n = 6)
18.2 6 0.7 4.25 6 0.20
Castrated + vehicle
(n = 6)
15.1 6 2.2 3.41 6 0.43
Sham-operated
(n = 6)
20.5 6 2.3 4.62 6 0.55
aDifferences between all groups are not signi®cant.
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the opposing effects of testosterone versus estrogen on skin
development could explain the persistence of increased mortality
in premature male versus female infants during the surfactant-
replacement era (Khoury et al, 1985; La Pine et al, 1995; Williams
et al, 1998).
Although the consequences for the fetus seem clear, the
potential clinical implications of compromised barrier home-
ostasis in testosterone-replete adults are still unclear. Common
skin diseases, such as atopic dermatitis, psoriasis, and irritant/
occupational dermatitis, appear to be as common in females as
in males (Diepgen and Coenraads, 1999; Laughter et al, 2000).
Moreover, female humans are not known to exhibit superior
barrier function to male humans (Lammintausta et al, 1987; Goh
and Chia, 1988; Reed et al, 1995). Thus, there is an apparent
paradox between our observations and the reported lack of
gender-related, clinical, and functional differences, which could
be explained by one or more of the following: (1) suf®cient
androgen metabolites could be generated in females to exert
similar effects; or (2) estrogens could exert comparable negative
effects on barrier homeostasis in adult females. Preliminary
studies in female mice, however, do not support either of these
possibilities: neither castration nor topical ¯utamide accelerate
barrier recovery in adult female mice (Kao J, Elias PM,
Feingold KR, unpublished preliminary observations). At least
Figure 9.The lamellar body secretory response is impaired after acute barrier disruption. (A, C) Castrated plus testosterone-treated, 3 h after tape
stripping; (B, D) castrated plus vehicle-treated, 3 h after tape stripping. In vehicle-treated samples, much more secreted material appears at the SG±SC
interface than in testosterone-treated animals (B, solid white arrows versus A, open arrows). In addition, the extracellular processing of secreted lamellar material
after acute barrier disruption appears to be delayed in testosterone- versus vehicle-treated animals (in C versus D note persistence of unprocessed material; in A
versus B note replacement of mature lamellar bilayers by lacunae, A, asterisks; cf. B, small solid arrowheads = mature bilayers). (A, B) Ruthenium tetroxide; (C,
D) osmium tetroxide. Scale bars: 0.5 mm.
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one additional possibility remains; i.e., that gender-related
differences in function could be unearthed in future studies.
Indeed, one recent epidermiologic study found a male
preponderance for adult psoriatics, accounted for solely by an
increased disease incidence in males in the second through
fourth decades (Raychaudhuri and Gross, 2000), a shift in
incidence that coincides with peak androgen production in
males. Moreover, gender, through its impact on barrier
function, could also in¯uence disease severity, rather than
disease pevalence. Many clinical dermatologists note that severe
atopic dermatitis (Paller A, Williams ML, Luck AW, personal
communication, March 2000) and severe psoriasis (Krueger GR,
personal communication), diseases that are associated with
barrier abnormalities, occur more commonly in males than in
females. Yet, the impact of gender on the severity of skin
disease has not been studied systematically.
Androgens reportedly stimulate both epidermal mitogenesis
and differentiation (Montagna et al, 1949; Eartly et al, 1951;
Zackheim, 1968; Tammi, 1982; Tammi and Santti, 1989);
however, in our system, testosterone repletion instead induced a
modest decrease in epidermal thickness. Whether this observa-
tion contributes to the testosterone-induced delay in barrier
recovery is unclear. Certainly, a decrease in the number of
nucleated cell layers could result in fewer cells available for
lamellar body production (see below). Our functional observa-
tions cannot, however, be explained by altered epidermal or
sebaceous lipid synthesis, because: (a) epidermal lipogenesis was
comparable in testosterone-replete versus hypogonadal animals,
these results are consistent with prior observations that lipid
synthesis is actually more robust in male versus female
mammalian epidermis (Feingold et al, 1982, 1983); (b) topical
¯utamide actually inhibits lipogenesis in sebaceous glands
(Lutsky et al, 1975); and (c) barrier homeostasis is normal in
asebia-J1 mice, which demonstrate profound sebaceous gland
hyperplasia.2
In the absence of a change in lipid synthesis abnormality, we
examined alternate, distal mechanisms as contributors to the
androgen effects on barrier homeostasis. In addition to lipid
synthesis, barrier homeostasis requires the assembly and secretion
of epidermal lamellar bodies, followed by postsecretory,
extracellular processing (Elias and Menon, 1991; Elias and
Feingold, 1992; Elias, 1996). The epidermal lamellar body is a
unique secretory organelle that delivers lipid precursors and
hydrolytic enzymes to the SC interstices, leading to barrier
formation (Elias and Menon, 1991; Elias and Feingold, 1992).
This organelle is a product of an extensive trans-Golgi network
in the apical cytosol of the outermost SG (Elias et al, 1998),
which ampli®es organelle secretion in response to barrier
perturbation (Elias and Feingold, 1992; Elias et al, 1998). In
addition to a potential reduction in the number of cells
available for LB formation, we found a signi®cant reduction in
LB density/cell in testosterone-treated animals: however, despite
the acknowledged importance of acylglycosylceramide produc-
tion for LB generation (Madison et al, 1998), synthesis of
glucosylceramides did not decline in parallel with reduced LB
formation in testosterone-replete animals.
In addition to decreased LB production, we observed a
downstream diminution in LB secretion and postsecretory,
extracellular processing. The observed decrease in secretion
could simply re¯ect decreased LB production, or alternatively
the reduction in LB secretion could result from other
mechanisms; e.g., testosterone-induced changes in the epidermal
calcium gradient (Menon et al, 1985), which directly regulates
LB secretion (Menon et al, 1994). Further mechanistic studies
will be required to delineate the apparent link between changes
in testosterone levels, barrier function, and LB production, as
well as the basis for the observed androgen effects on SC
integrity (cohesion).
Sue Allen capably edited and prepared this manuscript. These studies were supported
by NIH grants AR 19098, AR 39639, AR 394408 (PP), and the Medical
Research Service, Veterans Administration.
REFERENCES
Allen MC, Donohue PK, Dusman AE: The limit of viability ± neonatal
outcome of infants born at 22±25 weeks' gestation. N Engl J Med
329:1597±1601, 1993
Bingham KD, Shaw DA: The metabolism of testosterone by human male scalp skin. J
Endocrinol 57:111±121, 1973
BlaÈuer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P: Location of
androgen receptor in human skin. J Invest Dermatol 97:264±268, 1991
Coulam CB, Razel AJ, Kelalis PP, Svensson J, Spelsberg TC: Androgen receptor in
human foreskin. II. Characterization of the receptor from hypospadiac tissue.
Am J Obstet Gynecol 147:513±520, 1983
Diepgen TL, Coenraads PJ: The epidemiology of occupational contact dermatitis. Int
Arch Occ Environ Health 72:496±506, 1999
DubeÂ JY, Ngo-Thi NH, Tremblay RR: In vivo effects of steroid hormones on the
testosterone 5alpha-reductase in skin. Endocrinol 97:211±214, 1975
Eartly H, Grad B, LeBlond C: The antagonistic relatonship between testosterone and
thyroxine in maintaining the epidermis of the male rat. Endocrinology
49:677±686, 1951
Ebling F: The action of testosterone on the sebaceous glands and epidermis in
castrated and hypophysectomized male rats. J Endocrinol 5:297±306, 1957
Eicheler W, Dreher M, Hoffmann R, Happle R, AumuÈller G: Immunohistochemical
evidence for differential distribution of 5 alpha-reductase isoenzymes in human
skin. Br J Dermatol 133:371±376, 1995
Elias PM: Stratum corneum architecture, metabolic activity and interactivity with
subjacent cell layers. Exp Dermatol 5:191±201, 1996
Elias PM, Feingold KR: Lipids and the epidermal water barrier: metabolism,
regulation, and pathophysiology. Semin Dermatol 11:176±182, 1992
Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal
permeability barrier. Adv Lipid Res 24:1±26, 1991
Elias PM, Cullander C, Mauro T, Rassner U, KoÈmuÈves L, Brown BE, Menon GK:
The secretory granular cell: the outermost granular cell as a specialized
secretory cell. J Invest Dermatol Symp Proc 3:87±100, 1998
Feingold KR, Wiley MH, Moser AH, Lau DT, Lear SR, Siperstein MD: De novo
sterologenesis in intact primates. J Lab Clin Med 100:405±410, 1982
Feingold KR, Brown BE, Lear SR, Moser AH, Elias PM: Localization of de novo
sterologenesis in mammalian skin. J Invest Dermatol 81:365±369, 1983
Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM: The aged
epidermal permeability barrier. Structural, functional, and lipid biochemical
abnormalities in humans and a senescent murine model. J Clin Invest
95:2281±2290, 1995
Goh CL, Chia SE: Skin irritability to sodium lauryl sulphate ± as measured by skin
water vapour loss-by sex and race. Clin Exp Dermatol 13:16±19, 1988
Grubauer G, Feingold KR, Elias PM: Relationship of epidermal lipogenesis to
cutaneous barrier function. J Lipid Res 28:746±752, 1987
Hanley K, Rassner U, Jiang Y, et al: Hormonal basis for the gender difference in
epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay
by testosterone. J Clin Invest 97:2576±2584, 1996
Holleran WM, Mao-Qiang M, Gao WN, Menon GK, Elias PM, Feingold KR:
Sphingolipids are required for mammalian barrier function: Inhibition of
sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin
Invest 88:1338±1345, 1991
Hou SY, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM: Membrane
structures in normal and essential fatty acid-de®cient stratum corneum:
characterization by ruthenium tetroxide staining and x-ray diffraction. J
Invest Dermatol 96:215±223, 1991
Khoury MJ, Marks JS, McCarthy BJ, Zaro SM: Factors affecting the sex differential
in neonatal mortality: the role of respiratory distress syndrome. Am J Obstet
Gynecol 151:777±782, 1985
Komori H, Ichikawa S, Hirabayashi Y, Ito M: Regulation of intracellular ceramide
content in B16 melanoma cells: Biological implications of ceramide
glycosylation. J Biol Chem 274:8981±8987, 1999
La Pine TR, Jackson JC, Bennett FC: Outcome of infants weighing less than 800
grams at birth: 15 years' experience. Pediatrics 96:479±483, 1995
Lammintausta K, Maibach HI, Wilson D: Irritant reactivity in males and females.
Contact Dermatitis 17:276±280, 1987
Laughter D, Istvan J, Tofte S, Hani®n J: The prevalence of atopic dermatitis in
oregon schoolchildren. J Am Acad Dermatol 43:649±655, 2000
Lutsky BN, Budak M, Koziol P, Monahan M, Neri RO: The effects of a nonsteroid
antiandrogen, ¯utamide, on sebaceous gland activity. J Invest Dermatol
64:412±417, 1975
Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez Solache I, Singh M, Labrie F:
2Man M-Q, Wertz PW, Feingold KR, Elias PM: Barrier function and
moisturization in asebia mice: Function of cutaneous sebaceous glands.
J Invest Dermatol 114:796, 2000 (abstr.)
450 KAO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Characterization, expression, and immunohistochemical localization of 5
alpha-reductase in human skin. J Invest Dermatol 102:221±226, 1994
Madison KC, Sando GN, Howard EJ, True CA, Gilbert D, Swartzendruber DC,
Wertz PW: Lamellar granule biogenesis: a role for ceramide glucosyltransferase,
lysosomal enzyme transport, and the golgi. J Invest Dermatol Symp Proc The
3:80±86, 1998
Mao-Qiang M, Elias PM, Feingold KR: Fatty acids are required for epidermal
permeability barrier function. J Clin Invest 92:791±798, 1993
Menon GK, Grayson S, Elias PM: Ionic calcium reservoirs in mammalian epidermis:
Ultrastructural, localization by ion-capture cytochemistry. J Invest Dermatol
84:508±512, 1985
Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration
of the epidermal calcium gradient leads to enhanced lamellar body secretion. J
Invest Dermatol 102:789±795, 1994
Monger DJ, Williams ML, Feingold KR, Brown BE, Elias PM: Localization of
sites of lipid biosynthesis in mammalian epidermis. J Lipid Res 29:603±612,
1988
Montagna W, Kenyon P, Hamilton J: Mitotic activity in the epidermis of the rabbit
stimulated with local applications of testosterone propionate. J Exper Zool
110:379±396, 1949
Mowszowicz I, Riahi M, Wright F, Bouchard P, Kuttenn F, Mauvais-Jarvis P:
Androgen receptor in human skin cytosol. J Clin Endocrinol Metab 52:338±344,
1981
Overpeck JG, Colson SH, Hohmann JR, Applestine MS, Reilly JF: Concentrations
of circulating steroids in normal prepubertal and adult male and female humans,
chimpanzees, rhesus monkeys, rats, mice, and hamsters: a literature survey. J
Toxicol Environ Health 4:785±803, 1978
Randall VA, Ebling FJ: Is the metabolism of testosterone to 5 alpha-
dihydrotestosterone required for androgen action in the skin? Br J Dermatol
107 (Suppl. 23):47±53, 1982
Rassner U, Feingold KR, Crumrine DA, Elias PM: Coordinate assembly of
lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell
31:489±498, 1999
Raychaudhuri SP, Gross J: A comparative study of pediatric onset psoriasis with adult
onset psoriasis. Ped Dermatol 17:174±178, 2000
Reed JT, Ghadially R, Elias PM: Skin type, but neither race nor gender,
in¯uence epidermal permeability barrier function. Arch Dermatol
131:1134±1138, 1995
Sansone G, Reisner RM: Differential rates of conversion of testosterone to
dihydrotestosterone in acne and in normal human skin ± a possible
pathogenic factor in acne. J Invest Dermatol 56:366±372, 1971
Takayasu S, Wakimoto H, Itami S, Sano S: Activity of testosterone 5 alpha-reductase
in various tissues of human skin. J Invest Dermatol 74:187±191, 1980
Tammi R: Effects of sex steroids on human skin in organ culture. Acta Derm Venereol
62:107±112, 1982
Tammi R, Santti R: Morphometric analysis of human epidermis treated with
testosterone and dehydroepiandrosterone in organ culture. Arch Dermatol Res
281:417±423, 1989
Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S: Activity of the type 1,
5 alpha-reductase exhibits regional differences in isolated sebaceous glands and
whole skin. J Invest Dermatol 105:209±214, 1995
Williams M, Hanley K, Elias P, Feingold K: Ontogeny of the epidermal permeability
barrier. J Invest Dermatol Symp Proc The 3:75±79, 1998
Wilson JD, Lasnitzki I: Dihydrotestosterone formation in fetal tissues of the rabbit
and rat. Endocrinol 89:659±668, 1971
Wilson JD, Walker JD: The conversion of testosterone to 5 alpha-androstan-17 beta-
ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest 48:371±379,
1969
Zackheim HS: Effect of prolonged administration of testosterone on the epidermis of
female rats. J Invest Dermatol 50:401±404, 1968
VOL. 116, NO. 3 MARCH 2001 TESTOSTERONE PERTURBS BARRIER FUNCTION 451
